ArticleFrontiers in immunology2022

Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22).

Xilin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.